The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oh, J.-W.
Right arrow Articles by Benveniste, E. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oh, J.-W.
Right arrow Articles by Benveniste, E. N.
The Journal of Immunology, 2001, 166: 2695-2704.
Copyright © 2001 by The American Association of Immunologists

CXC Chemokine Receptor 4 Expression and Function in Human Astroglioma Cells1

Jae-Wook Oh2, Kathryn Drabik, Olaf Kutsch, Chulhee Choi, Albert Tousson and Etty N. Benveniste

Department of Cell Biology, University of Alabama, Birmingham, AL 35294

Chemokines constitute a superfamily of proteins that function as chemoattractants and activators of leukocytes. Astrocytes, the major glial cell type in the CNS, are a source of chemokines within the diseased brain. Specifically, we have shown that primary human astrocytes and human astroglioma cell lines produce the CXC chemokines IFN-{gamma}-inducible protein-10 and IL-8 and the CC chemokines monocyte chemoattractant protein-1 and RANTES in response to stimuli such as TNF-{alpha}, IL-1{beta}, and IFN-{gamma}. In this study, we investigated chemokine receptor expression and function on human astroglioma cells. Enhancement of CXC chemokine receptor 4 (CXCR4) mRNA expression was observed upon treatment with the cytokines TNF-{alpha} and IL-1{beta}. The peak of CXCR4 expression in response to TNF-{alpha} and IL-1{beta} was 8 and 4 h, respectively. CXCR4 protein expression was also enhanced upon treatment with TNF-{alpha} and IL-1{beta} (2- to 3-fold). To study the functional relevance of CXCR4 expression, stable astroglioma transfectants expressing high levels of CXCR4 were generated. Stimulation of cells with the ligand for CXCR4, stromal cell-derived factor-1{alpha} (SDF-1{alpha}), resulted in an elevation in intracellular Ca2+ concentration and activation of the mitogen-activated protein kinase cascade, specifically, extracellular signal-regulated kinase 2 (ERK2) mitogen-activated protein kinase. Of most interest, SDF-1{alpha} treatment induced expression of the chemokines monocyte chemoattractant protein-1, IL-8, and IFN-{gamma}-inducible protein-10. SDF-1{alpha}-induced chemokine expression was abrogated upon inclusion of U0126, a pharmacological inhibitor of ERK1/2, indicating that the ERK signaling cascade is involved in this response. Collectively, these data suggest that CXCR4-mediated signaling pathways in astroglioma cells may be another mechanism for these cells to express chemokines involved in angiogenesis and inflammation.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. Kerfoot, G. Andonegui, C. S. Bonder, and L. Liu
Exogenous stromal cell-derived factor-1 induces modest leukocyte recruitment in vivo
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2524 - H2534.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Yang, M. Koupenova, D. J. McCrann, K. J. Kopeikina, H. M. Kagan, B. M. Schreiber, and K. Ravid
The A2b adenosine receptor protects against vascular injury
PNAS, January 15, 2008; 105(2): 792 - 796.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Piovan, V. Tosello, S. Indraccolo, M. Masiero, L. Persano, G. Esposito, R. Zamarchi, M. Ponzoni, L. Chieco-Bianchi, R. Dalla-Favera, et al.
Differential Regulation of Hypoxia-Induced CXCR4 Triggering during B-Cell Development and Lymphomagenesis
Cancer Res., September 15, 2007; 67(18): 8605 - 8614.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
F. Barbieri, A. Bajetto, C. Porcile, A. Pattarozzi, G. Schettini, and T. Florio
Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function
J. Mol. Endocrinol., March 1, 2007; 38(3): 383 - 389.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
I. Kryczek, S. Wei, E. Keller, R. Liu, and W. Zou
Stroma-derived factor (SDF-1/CXCL12) and human tumor pathogenesis
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C987 - C995.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Zhang, S. Sarkar, and V.W. Yong
The chemokine stromal cell derived factor-1 (CXCL12) promotes glioma invasiveness through MT2-matrix metalloproteinase
Carcinogenesis, December 1, 2005; 26(12): 2069 - 2077.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Miwa, A. Mizokami, E. T. Keller, R. Taichman, J. Zhang, and M. Namiki
The Bisphosphonate YM529 Inhibits Osteolytic and Osteoblastic Changes and CXCR-4-Induced Invasion in Prostate Cancer
Cancer Res., October 1, 2005; 65(19): 8818 - 8825.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
Y. Zhou, X. Bian, Y. Le, W. Gong, J. Hu, X. Zhang, L. Wang, P. Iribarren, R. Salcedo, O. M. Z. Howard, et al.
Formylpeptide Receptor FPR and the Rapid Growth of Malignant Human Gliomas
J Natl Cancer Inst, June 1, 2005; 97(11): 823 - 835.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Katayama, T. Ogino, N. Bandoh, S. Nonaka, and Y. Harabuchi
Expression of CXCR4 and Its Down-Regulation by IFN-{gamma} in Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., April 15, 2005; 11(8): 2937 - 2946.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
S.-B. Peng, V. Peek, Y. Zhai, D. C. Paul, Q. Lou, X. Xia, T. Eessalu, W. Kohn, and S. Tang
Akt Activation, but not Extracellular Signal-Regulated Kinase Activation, Is Required for SDF-1{alpha}/CXCR4-Mediated Migration of Epitheloid Carcinoma Cells
Mol. Cancer Res., April 1, 2005; 3(4): 227 - 236.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Barbero, R. Bonavia, A. Bajetto, C. Porcile, P. Pirani, J. L. Ravetti, G. L. Zona, R. Spaziante, T. Florio, and G. Schettini
Stromal Cell-derived Factor 1{alpha} Stimulates Human Glioblastoma Cell Growth through the Activation of Both Extracellular Signal-regulated Kinases 1/2 and Akt
Cancer Res., April 15, 2003; 63(8): 1969 - 1974.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. H. Hwang, J. H. Hwang, H. K. Chung, D. W. Kim, E. S. Hwang, J. M. Suh, H. Kim, K.-H. You, O-Y. Kwon, H. K. Ro, et al.
CXC Chemokine Receptor 4 Expression and Function in Human Anaplastic Thyroid Cancer Cells
J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 408 - 416.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Zhou, P. H. Larsen, C. Hao, and V. W. Yong
CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival
J. Biol. Chem., December 13, 2002; 277(51): 49481 - 49487.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. P. Schneider, R. Salcedo, H. F. Dong, H. K. Kleinman, J. J. Oppenheim, and O. M. Z. Howard
Suradista NSC 651016 Inhibits the Angiogenic Activity of CXCL12-Stromal Cell-derived Factor 1{alpha}
Clin. Cancer Res., December 1, 2002; 8(12): 3955 - 3960.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Odemis, B. Moepps, P. Gierschik, and J. Engele
Interleukin-6 and cAMP Induce Stromal Cell-derived Factor-1 Chemotaxis in Astroglia by Up-regulating CXCR4 Cell Surface Expression. IMPLICATIONS FOR BRAIN INFLAMMATION
J. Biol. Chem., October 11, 2002; 277(42): 39801 - 39808.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. B. Huber, H. C. Reinhardt, M. Exner, J. A. Burger, D. Kerjaschki, M. A. Saleem, and H. Pavenstadt
Expression of Functional CCR and CXCR Chemokine Receptors in Podocytes
J. Immunol., June 15, 2002; 168(12): 6244 - 6252.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.